吉诺卫

Genovax is a clinical-stage biotechnology company based in Shanghai, China, specializing in the development of innovative recombinant protein vaccines. The company focuses on addressing significant unmet medical needs in infectious diseases, with a primary pipeline targeting Respiratory Syncytial Virus (RSV), Herpes Zoster (Shingles), and Human Papillomavirus (HPV). Genovax utilizes advanced protein engineering and adjuvant technologies to enhance the immunogenicity and safety profiles of its vaccine candidates. Its lead program for RSV is currently in clinical trials, positioning the company as a key player in the emerging Chinese vaccine innovation landscape.